This finding was validated in another study42; EVs derived from breast cancer cells undergoing ERS carry miR-27a-3p, which targets the ERS-related protein MAGI2 to downregulate PTEN, thereby promoting PD-L1 expression in M2 macrophages. The gene discussed is CD274; the disease is breast carcinoma.